Established in 1986 in Stockholm, Sweden, Mabtech develops and produces a wide range of monoclonal antibodies to cytokines, immunoglobulins and apolipoproteins for in vitro applications in life science research. With products frequently found in high impact publications, Mabtech’s quality management system complies with ISO 9001 and ISO 13485 and is reviewed annually by external audit.
Mabtech’s mission is to assist researchers with high-quality, dependable research tools, and are one of few companies focusing entirely on monoclonal antibodies for ELISpot, FluoroSpot and ELISA. This position was established through comprehensive experience and understanding of all stages of monoclonal antibody development and production. Stringent quality control and validation processes ensure the stability, activity, and performance of optimized antibody pairs.
In addition to the production of kits used to study infectious diseases, cancer, allergy and transplantation, Mabtech readers have been developed to deliver unbiased spot analysis by combining an innovative algorithm with state-of-the-art hardware. Mabtech IRIS™ is a next-generation 4-color FluoroSpot/ELISpot reader enabling reliable multiplexing. The Mabtech ASTOR™ reader offers the same innovative and user-friendly technology but for ELISpot only labs.
Popular product ranges:
- IL-6 – a range of FluoroSpot, ELISpot and ELISA kits, and antibodies for detection of interleukin-6. IL-6 is a proinflammatory cytokine secreted in response to infection or tissue injury.
- TNF-α – a range of FluoroSpot, ELISpot and ELISA kits, and antibodies for detection of tumour necrosis factor-α in multiple species. TNF-α is a proinflammatory cytokine produced primarily by activated macrophages and is involved in the acute phase immune response.
- IFN-γ – a wide range of FluoroSpot, ELISpot and ELISA kits, and antibodies for detection of interferon-γ in multiple species. IFN-γ is a proinflammatory cytokine produced mainly by activated T cells and NK cells in response to intracellular pathogens.